Cancer biotech upstart grabs $18M round, sets out to master relapsed prostate cancer
UC San Francisco researcher Bin Liu has spent years in the lab studying how to tackle prostate cancer cells. Recently, he’s been making progress on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
